Publications
Export 36 results:
Filters: Author is Marie-France Demers [Clear All Filters]
, “Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.”, J Psychopharmacol, vol. 22, no. 3, pp. 262-9, 2008.
, “[Improving detection and treatment of early psychosis in Québec: the Quebec association of early psychosis (l'Association québécoise des programmes pour premiers épisodes psychotiques, AQPPEP), sees to it].”, Sante Ment Que, vol. 32, no. 1, pp. 299-315, 2007.
, “Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.”, Curr Med Res Opin, vol. 22, no. 7, pp. 1277-85, 2006.
, “Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.”, J Clin Psychiatry, vol. 65, no. 4, pp. 557-64, 2004.
, “First person account: Susan's cello.”, Schizophr Bull, vol. 28, no. 1, pp. 187-9, 2002.
, “Atypical antipsychotics and cardiovascular risk in schizophrenic patients.”, J Clin Psychopharmacol, vol. 21, no. 1, pp. 110-1, 2001.
, “[Psychosis and addiction: the experience of the Polyclinique Sainte-Anne.].”, Sante Ment Que, vol. 26, no. 2, pp. 62-91, 2001.
, “Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group.”, J Clin Psychopharmacol, vol. 20, no. 3, pp. 295-304, 2000.
, “[Schizophrenia and psychoactive drug abuse: dual diagnostic problem].”, Can J Psychiatry, vol. 45, no. 6, pp. 572-3, 2000.
, “Visual and auditory hallucinations with the association of bupropion and valproate.”, Can J Psychiatry, vol. 45, no. 2, pp. 198-9, 2000.
, “Empowering the staff in long-stay wards.”, Can J Psychiatry, vol. 43, no. 10, pp. 1054-5, 1998.
